Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2022-12-16 2023-03-02 178790
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2023-01-06 2023-01-20 180081
APO-FAMCICLOVIR 250MG TABLET Resolved 2023-01-06 2023-02-09 180116
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Actual shortage 2023-01-30 2023-07-31 182684
APO-CEFUROXIME 250MG TABLET Resolved 2023-02-02 2023-02-09 183495
APO-LEVOFLOXACIN 250MG TABLET Resolved 2023-02-16 2023-05-06 185010
APO-CEPHALEX 250MG TABLET Resolved 2023-03-02 2023-04-14 185939
APO-LEVETIRACETAM 250MG TABLET Resolved 2023-04-14 2023-06-23 189641
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-21 2023-06-23 189991
APO-AZITHROMYCIN Z 250MG TABLET Resolved 2023-04-21 2023-06-23 190002
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-05-06 190846
APO-TERBINAFINE 250MG TABLET Resolved 2023-05-26 2023-06-16 193212
APO-ABIRATERONE FILM COATED TABLETS 250MG TABLET Resolved 2023-06-09 2023-07-13 194577
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Actual shortage 2023-06-09 2023-09-06 194593
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2023-06-16 2023-07-07 195097
APO-CEPHALEX 250MG TABLET Resolved 2023-07-07 2024-01-12 197876
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2023-07-21 2023-10-27 199533
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-08-12 2023-11-17 201699
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2023-09-07 2023-09-15 203819
APO-CLARITHROMYCIN 250MG TABLET Resolved 2023-09-07 2023-09-15 203828

Showing 1501 to 1520 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 356